Cargando…
Aberrant Methylation of PCDH8 is a Potential Prognostic Biomarker for Patients with Clear Cell Renal Cell Carcinoma
BACKGROUND: PCDH8 is a tumor suppressor that regulates cell adhesin, proliferation, and migration. It is often inactivated by aberrant promoter methylation in several human cancers, including clear cell renal cell carcinoma (CCRCC). The clinical significance of PCDH8 methylation in CCRCC remains unc...
Autores principales: | Lin, Ying-Li, Wang, Yan-Ling, Fu, Xing-Li, Ma, Jian-Guo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251547/ https://www.ncbi.nlm.nih.gov/pubmed/25416427 http://dx.doi.org/10.12659/MSM.892433 |
Ejemplares similares
-
Aberrant Methylation of PCDH10 Predicts Worse Biochemical Recurrence-Free Survival in Patients with Prostate Cancer After Radical Prostatectomy
por: Wang, Li, et al.
Publicado: (2014) -
Protocadherin 8 (PCDH8) Inhibits Proliferation, Migration, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma
por: Yu, Hong, et al.
Publicado: (2020) -
Promoter Methylation of Protocadherin8 is an Independent Prognostic Factor for Biochemical Recurrence of Early-Stage Prostate Cancer
por: Niu, Wen-Bin, et al.
Publicado: (2014) -
CBX8 and CD96 Are Important Prognostic Biomarkers of Colorectal Cancer
por: Song, Xin, et al.
Publicado: (2018) -
Aberrant Methylation of Protocadherin 17 and its Clinical Significance in Patients with Prostate Cancer after Radical Prostatectomy
por: Lin, Ying-Li, et al.
Publicado: (2014)